Sign Up to like & get
recommendations!
0
Published in 2018 at "General physiology and biophysics"
DOI: 10.4149/gpb_2017063
Abstract: Selective inhibition of BET Brd2 BD-I and BD-II bromodomains is expected to elicit subtle pharmacological difference in anti-glioblastoma therapy. Here, structural basis and energetic property underlying the selective interaction of acetylated peptide ligands with Brd2…
read more here.
Keywords:
secondary anchor;
anchor residues;
acetylated peptide;
peptide selectivity ... See more keywords